As of 2025-12-27, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (16.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.85 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -667.6%.
The range of the Relative Valuation is (14.72) - (18.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 18.0x | 15.8x |
| Forward P/E multiples | 14.7x - 18.3x | 16.5x |
| Fair Price | (14.72) - (18.03) | (16.18) |
| Upside | -616.7% - -732.6% | -667.6% |
| Date | P/E |
| 2025-12-26 | -2.86 |
| 2025-12-24 | -2.87 |
| 2025-12-23 | -2.82 |
| 2025-12-22 | -2.78 |
| 2025-12-19 | -2.48 |
| 2025-12-18 | -2.46 |
| 2025-12-17 | -2.52 |
| 2025-12-16 | -2.25 |
| 2025-12-15 | -2.16 |
| 2025-12-12 | -2.20 |
| 2025-12-11 | -2.25 |
| 2025-12-10 | -2.26 |
| 2025-12-09 | -2.25 |
| 2025-12-08 | -2.31 |
| 2025-12-05 | -2.20 |
| 2025-12-04 | -2.20 |
| 2025-12-03 | -2.21 |
| 2025-12-02 | -2.13 |
| 2025-12-01 | -2.23 |
| 2025-11-28 | -2.47 |
| 2025-11-26 | -2.44 |
| 2025-11-25 | -2.48 |
| 2025-11-24 | -2.50 |
| 2025-11-21 | -2.24 |
| 2025-11-20 | -2.18 |
| 2025-11-19 | -2.26 |
| 2025-11-18 | -2.44 |
| 2025-11-17 | -2.42 |
| 2025-11-14 | -2.47 |
| 2025-11-13 | -2.41 |
| 2025-11-12 | -2.54 |
| 2025-11-11 | -2.65 |
| 2025-11-10 | -2.37 |
| 2025-11-07 | -2.30 |
| 2025-11-06 | -2.31 |
| 2025-11-05 | -1.81 |
| 2025-11-04 | -1.82 |
| 2025-11-03 | -1.95 |
| 2025-10-31 | -1.97 |
| 2025-10-30 | -1.95 |
| 2025-10-29 | -2.00 |
| 2025-10-28 | -2.19 |
| 2025-10-27 | -2.31 |
| 2025-10-24 | -2.25 |
| 2025-10-23 | -2.19 |
| 2025-10-22 | -2.15 |
| 2025-10-21 | -2.27 |
| 2025-10-20 | -2.32 |
| 2025-10-17 | -2.18 |
| 2025-10-16 | -2.24 |